COX-2 inhibition attenuates cough reflex sensitivity to inhaled capsaicin in patients with asthma

Journal of Investigational Allergology and Clinical Immunology

Volumn 19, Issue 5, 2009, Pages 370-374

  Ishiura, Yoshihisa ^a   Fujimura, M ^b   Yamamoto, H ^a   Ishiguro, T ^b   Ohkura, N ^b   Myou, S ^b  

^a TOYAMA CITY HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Airway cough reflexsensitivity; Bronchial asthma; Capsaicin; COX 2; Etodolac

Indexed keywords

CAPSAICIN; CYCLOOXYGENASE 2; ETODOLAC; PLACEBO;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SCANNING ELECTRON MICROSCOPY; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; CAPSAICIN; COUGH; CROSS-OVER STUDIES; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; ETODOLAC; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; VITAL CAPACITY;

EID: 70350212571     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Barnes PJ. Mechanisms: inflammation. In: Weiss EB, Stein M Eds. Bronchial Asthma, Mechanisms and Therapeutics. 3rd ed. Boston, Toronto, London: Little, Brown and Co., 1993;80-94.
2. Wenzel SE. Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy. 1997;17:3S-12S.
3. Henderson WR Jr. Role of leukotrienes in asthma. Ann Allergy. 1994;72:272-278
4. O'Byrne PM. Leukotrienes in the pathogenesis of asthma. Chest. 1997;111:27S-34S.
5. Samuelsson B. An elucidation of the arachidonic acid cascade. Discovery of prostaglandins, thromboxane and leukotrienes. Drugs. 1987;33:2-9.
6. Smith WL, Dewitt DL. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol. 1996;62:167-215.
7. Sousa AR, Pfister R, Christie PE, Lane SJ, Nasser SM, Schmitz- Schumann M, Lee TH. Enhanced expression of cyclo-oxygenase 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin sensitive asthma. Thorax 1997;52:940-945. (Pubitemid 27514487)
8. Pang L, Pitt A, Petkova D, Knox AJ.The COX-1/COX-2 balance in asthma. Clin Exp Allergy. 1998;28:1050-1058 (Pubitemid 28432626)
9. Belvisi MG, Saunders MA, Haddad el-B, Hirst SJ, Yacoub MH, Barnes PJ, Mitchell JA. Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol. 1997;120:910-916.
10. Fujimura M, Kamio Y, Kasahara K, Bando T, Hashimoto T, Matsuda T. Prostanoids and cough response to capsaicin in asthma and chronic bronchitis. Eur Respir J. 1995;8:1499-1505.
11. Dicpinigaitis PV. Effect of the cyclooxygenase-2 inhibitor celecoxib on bronchial responsiveness and cough reflex sensitivity in asthmatics. Pulm Pharmacol Ther. 2001;14:93-97
12. Kamei J, Matsunawa Y and Saitoh A. Antitussive effect of NS- 398, a selective cyclooxygenase-2 inhibitor, in guinea pigs. Eur J Pharmacol. 2004;497:233-239. (Pubitemid 39099222)
13. Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 2004;18:790-804.
14. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR.Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999 Jun 22;96:7563-7568
15. American Thoracic Society. - Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 1987;136:225-244.
16. Fujimura M, Sakamoto S, Kamio Y, Matsuda T. Effects of methacholine-induced bronchoconstriction and procaterolinduced bronchodilation on cough receptor sensitivity to inhaled capsaicin and tartaric acid. Thorax. 1992;47:441-445
17. Bresalier R, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA. Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005;352:1092-1103.
18. Psaty BM, Furberg CD: COX-2 inhibitors - Lessons in drug safety. N Engl J Med. 2005;352:1133-1135 (Pubitemid 40365356)
19. Braman SS, Corrao WM. Chronic cough. Prim Care. 1985;12:217-225
20. Ishiura Y, Fujimura M, Nobata K, Oribe Y, Abo M, Myou S. Prostaglandin I2 enhances cough reflex sensitivity to capsaicin in the asthmatic airway. Cough. 2007;12;3:2.
21. Ishiura Y, Fujimura M, Nobata K, Abo M, Oribe T, Myou S, Nakamura H. Phosphodiesterase 3 inhibition and cough in elderly asthmatics. Cough. 2005;24;1:11.
22. Ishiura Y, Fujimura M, Nobata K, Myou S, Oribe Y, Abo M, Nakamura H. Th2 cytokine inhibition and cough in asthmatic and bronchitic patients. Ann Med. 2004;3:623-629 (Pubitemid 40051439)
23. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol. 1999;104:5-13. (Pubitemid 29364472)
24. Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M. Safety of a specific COX-2 inhibitor in aspirininduced asthma. Clin Exp Allergy. 2001;31:219-225 (Pubitemid 32231856)
25. Martín-García C, Hinojosa M, Berges P, Camacho E, García-Rodriguez R, Alfaya T. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. J Investig Allergol Clin Immunol. 2003;13:20-25 (Pubitemid 36781519)
26. Woessner KM, Simon RA, Stevenson DD. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2004;93:339-344
27. Bavbek S, Celik G, Ozer F, Mungan D, Misirligil Z. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib. J Asthma. 2004;41:67-75. (Pubitemid 38366875)
28. Kowalski ML, Makowska J. Use of nonsteroidal anti-inflammatory drugs in patients with aspirin hypersensitivity: safety of cyclooxygenase- 2 inhibitors. Treat Respir Med. 2006;5:399-406. (Pubitemid 44968300)
29. Bavbek S, Dursun AB, Dursun E, Eryilmaz A, Misirligil Z. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study. Int Arch Allergy Immunol. 2007;142:64-69
30. Titchen T, Cranswick N, Beggs S. Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital. Br J Clin Pharmacol. 2005;59:718-723 (Pubitemid 40835506)
31. Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, Worchel J. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Drug Safety 2006;29:621-632 (Pubitemid 44175032)